146 related articles for article (PubMed ID: 26087671)
21. Enhancing regional control in p16-negative oropharyngeal cancer: A propensity score-matched analysis of upfront neck dissection and definitive chemoradiotherapy.
Lee TL; Fang WC; Lee IC; Lirng JF; Chang CF; Hsu YB; Chu PY; Wang YF; Yang MH; Chang PM; Wang LW; Tai SK
J Chin Med Assoc; 2024 May; 87(5):516-524. PubMed ID: 38501795
[TBL] [Abstract][Full Text] [Related]
22. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
Bar-Ad V; Wang ZX; Leiby B; Tuluc M
J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
[TBL] [Abstract][Full Text] [Related]
23. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
24. p16 expression in follicular dendritic cell sarcoma: a potential mimicker of human papillomavirus-related oropharyngeal squamous cell carcinoma.
Zhang L; Yang C; Lewis JS; El-Mofty SK; Chernock RD
Hum Pathol; 2017 Aug; 66():40-47. PubMed ID: 28554574
[TBL] [Abstract][Full Text] [Related]
25. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
[TBL] [Abstract][Full Text] [Related]
26. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
27. Management of the "violated neck" in the era of chemoradiation.
Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG
Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776
[TBL] [Abstract][Full Text] [Related]
28. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
Pellini R; Manciocco V; Turri-Zanoni M; Vidiri A; Sanguineti G; Marucci L; Sciuto R; Covello R; Sperduti I; Kayal R; Anelli V; Pichi B; Mercante G; Spriano G
J Craniomaxillofac Surg; 2014 Dec; 42(8):1834-9. PubMed ID: 25150165
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor.
Vainshtein J; McHugh JB; Spector ME; Walline HM; Komarck CM; Stenmark MH; Prince ME; Worden FP; Wolf GT; Bradford CR; Chepeha DB; Carey T; Eisbruch A
Head Neck; 2015 Jan; 37(1):8-11. PubMed ID: 24962247
[TBL] [Abstract][Full Text] [Related]
30. p16 expression in cutaneous squamous carcinomas with neck metastases: a potential pitfall in identifying unknown primaries of the head and neck.
Beadle BM; William WN; McLemore MS; Sturgis EM; Williams MD
Head Neck; 2013 Nov; 35(11):1527-33. PubMed ID: 23108906
[TBL] [Abstract][Full Text] [Related]
31. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
McMullen CP; Garneau J; Weimar E; Ali S; Farinhas JM; Yu E; Som PM; Sarta C; Goldstein DP; Su S; Xu W; Smith RV; Miles B; de Almeida JR
Oral Oncol; 2019 Jun; 93():96-100. PubMed ID: 31109703
[TBL] [Abstract][Full Text] [Related]
32. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
[TBL] [Abstract][Full Text] [Related]
33. [Planned neck dissection after weekly docetaxel and concurrent radiotherapy for advanced oropharyngeal cancer].
Tomita T; Ozawa H; Sakamoto K; Fujii R; Ogawa K; Fujii M; Yamashita T; Shinden S
Nihon Jibiinkoka Gakkai Kaiho; 2007 Mar; 110(3):95-102. PubMed ID: 17419444
[TBL] [Abstract][Full Text] [Related]
34. Influence of p16 status on indication and outcome of salvage neck dissection in oropharyngeal cancer.
Mueller SK; Mantsopoulos K; Semrau S; Agaimy A; Eckstein M; Traxdorf M; Gostian AO; Goncalves M; Sievert M; Haderlein M; Grundtner P; Hecht M; Koch M; Fietkau R; Iro H; Scherl C
Acta Otolaryngol; 2021 Feb; 141(2):187-192. PubMed ID: 33108949
[TBL] [Abstract][Full Text] [Related]
35. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.
O'Brien CJ; Traynor SJ; McNeil E; McMahon JD; Chaplin JM
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):360-5. PubMed ID: 10722009
[TBL] [Abstract][Full Text] [Related]
36. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
37. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
[TBL] [Abstract][Full Text] [Related]
38. p16
Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
[TBL] [Abstract][Full Text] [Related]
39. Degenerated Keratinized Tumor Cells in Oropharyngeal Human Papilloma Virus-Associated Squamous Cell Carcinoma: A Pitfall in p16 Immunostaining of Fine-Needle Aspiration Specimens.
Wei S; Ehya H
Acta Cytol; 2018; 62(5-6):339-345. PubMed ID: 29966127
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition.
Gurin D; Slavik M; Hermanova M; Shatokhina T; Sana J; Kazda T; Selingerova I; Ahmad P; Smilek P; Horakova Z; Hendrych M; Slampa P; Slaby O
J Oral Pathol Med; 2018 Oct; 47(9):864-872. PubMed ID: 30079604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
